Recent advances in treatment of severe primary immunodeficiencies

about

Recent advances in treatment of severe primary immunodeficiencies

Item

http://www.wikidata.org/entity/Q26766170

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Recent advances in treatment of severe primary immunodeficiencies

@ast

Recent advances in treatment of severe primary immunodeficiencies

@en

Recent advances in treatment of severe primary immunodeficiencies

@nl

type

Item

label

Recent advances in treatment of severe primary immunodeficiencies

@ast

Recent advances in treatment of severe primary immunodeficiencies

@en

Recent advances in treatment of severe primary immunodeficiencies

@nl

prefLabel

Recent advances in treatment of severe primary immunodeficiencies

@ast

Recent advances in treatment of severe primary immunodeficiencies

@en

Recent advances in treatment of severe primary immunodeficiencies

@nl

P1476

Recent advances in treatment of severe primary immunodeficiencies

@en

P2093

Andrew Gennery

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment

Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment

Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

CRISPR-Cas systems for editing, regulating and targeting genomes

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies

A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.

P31

scholarly article

P356

10.12688/F1000RESEARCH.7013.1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287405787

http://www.w3.org/2001/XMLSchema#string

P698

26918153

http://www.w3.org/2001/XMLSchema#string

P932

4754032

http://www.w3.org/2001/XMLSchema#string